Alibaba Selects TAUG as a Top 10 Exhibitor for its Upcoming Alibaba.com U.S. Supplements & Nutrition Online Tradeshow
June 22 2020 - 9:13AM
InvestorsHub NewsWire
The Company’s Presentation Slot is Confirmed for
July 10, 2020 (Day 4) - Market Segment: CBD –
BRANDED GOODS
Out of Over 100 Applications, Alibaba Selected
Tauriga Sciences, Inc. as a Top 10 Corporate
Exhibitor
NEW YORK, NY -- June 22, 2020 -- InvestorsHub
NewsWire -- Tauriga Sciences, Inc. (OTCQB: TAUG)
(“Tauriga” or the “Company”), a revenue generating, diversified
life sciences company, with a proprietary line of functional
“supplement” chewing gums (Flavors: Pomegranate, Blood Orange,
Peach-Lemon, Pear Bellini, Mint, Black Currant) as well as two
ongoing Biotechnology initiatives, today confirmed that its
presentation slot, at the upcoming Alibaba.com U.S. Supplements
& Nutrition Online Tradeshow (the “Event”), is set for July 10,
2020 (4thDay). Out of more than 100 applications,
Alibaba selected Tauriga Sciences, Inc. as a top 10 Corporate
Exhibitor. Alibaba has confirmed that the following large retail
buyers (“Big Buyers”) will be attending the presentation: GNC,
Costco, Miracle Leaf, KEHE, Tmall Global, and
AmerisourceBergen.
There will also be significant press and media
coverage for this event, including: Forbes, Pivot Story, Trade Fair
Times, and MDM.
Link to
Event:
https://www.alibaba-na.com/supplements_nutrition_buyer?spm=a272f.14988163.k0c925qn.1.62ae6394mTuJDq
The Company expects that the entirety of its
Tauri-Gum™ product line will be available, to showcase to the
prospective Buyers attending this Event. The Tauri-Gum™
product line is comprised of 6 distinct flavors/versions: [3] CBD
Infused (Pomegranate, Blood Orange, Mint), [2] CBG Infused
(Peach-Lemon, Black Currant), and [1] Immune Booster / Vitamin C
& Zinc Infused (Pear
Bellini).
CBD = Cannabidiol / CBG =
Cannabigerol
ABOUT TAURIGA SCIENCES,
INC.
Tauriga Sciences, Inc. (TAUG)
is a revenue generating, diversified life sciences company, engaged
in several major business activities and initiatives. The
company manufactures and distributes several proprietary retail
products and product lines, mainly focused on the Cannabidiol
(“CBD”) and Cannabigerol (“CBG”) Edibles market
segment. The main product line, branded as Tauri-Gum™,
consists of a proprietary supplement chewing gum that is both
Kosher certified and Vegan formulated (CBD Infused Tauri-Gum™
Flavors: Mint, Blood Orange, Pomegranate) & (CBG Infused
Tauri-Gum™ Flavor: Peach-Lemon). The Company’s
commercialization strategy consists of a broad array of retail
customers, distributors, and a fast-growing E-Commerce business
segment (E-Commerce website: www.taurigum.com). Please visit
our corporate website, for additional information, as well as
inquiries, at www.tauriga.com
Complementary to the Company’s retail business, are
its two ongoing biotechnology initiatives. The first one
relates to the development of a Pharmaceutical grade version of
Tauri-Gum™, for nausea regulation (specifically designed to help
patients that are subjected to ongoing chemotherapy
treatment). On March 18, 2020, the Company announced that it
filed a provisional U.S. patent application covering its
pharmaceutical grade version of Tauri-Gum™. The Patent, filed
with the U.S.P.T.O. is Titled “MEDICATED CBD COMPOSITIONS, METHODS
OF MANUFACTURING, AND METHODS OF TREATMENT”. The second one
relates to a collaboration agreement with Aegea Biotechnologies
Inc. for the co-development of a rapid, multiplexed, Novel
Coronavirus (COVID-19) test with superior sensitivity and
selectivity.
The Company is headquartered in New York City and
operates a regional office in Barcelona, Spain. In addition,
the Company operates a full-time E-Commerce fulfillment center
located in LaGrangeville, New
York.
DISCLAIMER -- Forward-Looking
Statements
This press release contains certain
“forward-looking statements” as defined by the Private Securities
Litigation Reform Act of 1995 which represent management’s beliefs
and assumptions concerning future events. These forward-looking
statements are often indicated by using words such as “may,”
“will,” “expects,” “anticipates,” believes, “hopes,” “believes,” or
plans, and may include statements regarding corporate objectives as
well as the attainment of certain corporate goals and milestones.
Forward-looking statements are based on present circumstances and
on management’s present beliefs with respect to events that have
not occurred, that may not occur, or that may occur with different
consequences or timing than those now assumed or anticipated.
Actual results may differ materially from those expressed in
forward-looking statements due to known and unknown risks and
uncertainties, such as are not guarantees of general economic and
business conditions, the ability to successfully develop and market
products, consumer and business consumption habits, the ability to
consummate successful acquisition and licensing transactions,
fluctuations in exchange rates, and other factors over which
Tauriga has little or no control. Many of these risks and
uncertainties are discussed in greater detail in the “Risk Factors”
section of Tauriga’s Form 10-K and other filings made from time to
time with the Securities and Exchange Commission. Such
forward-looking statements are made only as of the date of this
release, and Tauriga assumes no obligation to update
forward-looking statements to reflect subsequent events or
circumstances. You should not place undue reliance on these
forward-looking statements.
CONTACT INFORMATION
Tauriga Sciences, Inc.
555 Madison Avenue, 5th Floor
New York, NY 10022
Chief Executive Officer
Mr. Seth M. Shaw
Email: sshaw@tauriga.com
cell # (917) 796 9926
Instagram: @taurigum
Twitter: @SethMShaw
Corp. Website: www.tauriga.com
E-Commerce Website: www.taurigum.com
Tauriga Sciences (CE) (USOTC:TAUG)
Historical Stock Chart
From Aug 2024 to Sep 2024
Tauriga Sciences (CE) (USOTC:TAUG)
Historical Stock Chart
From Sep 2023 to Sep 2024